plerixafor has been researched along with Lichen Planus, Oral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crisóstomo, MF; González-Arriagada, WA; González-Díaz, P; Peña, C; Rivera, C | 1 |
1 other study(ies) available for plerixafor and Lichen Planus, Oral
| Article | Year |
|---|---|
Oral lichen planus interactome reveals CXCR4 and CXCL12 as candidate therapeutic targets.
Topics: Benzylamines; Chemokine CXCL12; Computational Biology; Cyclams; Female; Genetic Association Studies; Heterocyclic Compounds; Humans; Lichen Planus, Oral; Male; Molecular Targeted Therapy; Mouth Mucosa; Receptors, CXCR4; Up-Regulation | 2020 |